Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000040394 | SCV000051463 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040394 | SCV000064085 | benign | not specified | 2012-04-10 | criteria provided, single submitter | clinical testing | 2.1% (66/3130) of Afr American chrom from ESP |
Gene |
RCV000040394 | SCV000169303 | benign | not specified | 2014-04-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000230412 | SCV000286737 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000246059 | SCV000317922 | likely benign | Cardiovascular phenotype | 2012-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770005 | SCV000901431 | benign | Cardiomyopathy | 2017-08-15 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852837 | SCV000995567 | benign | Cardiomyopathy; Ventricular fibrillation | 2019-05-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529937 | SCV001474460 | benign | not provided | 2020-01-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040394 | SCV001478819 | likely benign | not specified | 2021-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000040394 | SCV001879672 | benign | not specified | 2021-01-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839633 | SCV002100451 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839634 | SCV002100452 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839635 | SCV002100453 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839632 | SCV002100455 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529937 | SCV001744292 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000040394 | SCV001925081 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000040394 | SCV001951420 | benign | not specified | no assertion criteria provided | clinical testing |